Gaslightwala Abizer
SEC insider (Form 3/4/5 filer). CIK 0002049375. CEO at Akari Therapeutics Plc (AKTX). 28 reported Form 4/5 transactions since Sep 2024; latest on Oct 14, 2026. Located in TAMPA, FL.
Companies Gaslightwala Abizer has filed insider reports for
- Akari Therapeutics Plc (AKTX): Director, Officer, CEO
Gaslightwala Abizer
CIK: 0002049375
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Akari Therapeutics Plc
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Oct 14, 2026AKTX
Akari Therapeutics Plc
ExerciseDirect19.3K shares at avg. $0.00$7.733 - Oct 14, 2026AKTX
Akari Therapeutics Plc
ExerciseDirect7.7K shares at avg. $0.00$3.093 - Sep 29, 2026AKTX
Akari Therapeutics Plc
AwardDirect6.4K shares at avg. $9.72$62K - Aug 18, 2026AKTX
Akari Therapeutics Plc
AwardDirectStock Option (Right to Buy)
174K shares- - Jun 24, 2026AKTX
Akari Therapeutics Plc
AwardDirectStock Option (Right to Buy)
15.6K shares- - Jun 24, 2026AKTX
Akari Therapeutics Plc
AwardDirectStock Option (Right to Buy)
5.5K shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectPre-Funded Warrants to purchase ADRs
773.3K shares at avg. $0.40- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectPre-Funded Warrants to purchase ADRs
309.3K shares at avg. $0.40- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectWarrants to purchase American Depositary Shares ("ADRs")
309.3K shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectWarrants to purchase ADRs
773.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 14, 2026 | AKTX Akari Therapeutics Plc | Exercise | 19,333 | $0.00 | $8 | Direct |
| Oct 14, 2026 | AKTX Akari Therapeutics Plc | Exercise | 7,733 | $0.00 | $3 | Direct |
| Sep 29, 2026 | AKTX Akari Therapeutics Plc | Award | 6,430 | $9.72 | $62,500 | Direct |
| Aug 18, 2026 | AKTX Akari Therapeutics Plc | Award Stock Option (Right to Buy) | 174,000 | - | - | Direct |
| Jun 24, 2026 | AKTX Akari Therapeutics Plc | Award Stock Option (Right to Buy) | 15,563 | - | - | Direct |
| Jun 24, 2026 | AKTX Akari Therapeutics Plc | Award Stock Option (Right to Buy) | 5,500 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Pre-Funded Warrants to purchase ADRs | 773,323 | $0.40 | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Pre-Funded Warrants to purchase ADRs | 309,328 | $0.40 | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Warrants to purchase American Depositary Shares ("ADRs") | 309,328 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Warrants to purchase ADRs | 773,323 | - | - | Direct |
1-10 of 28 transactions